LA JOLLA, CA--(Marketwire - November 06, 2007) - Transdel Pharmaceuticals, Inc. (OTCBB: TDLP), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically targeted medications, today announced that Anthony S. Thornley has been appointed to the Company’s Board of Directors.
